DK0614980T3 - Trans-dominante TAT-varianter fra humant immundeficiens-virus - Google Patents

Trans-dominante TAT-varianter fra humant immundeficiens-virus

Info

Publication number
DK0614980T3
DK0614980T3 DK94400005T DK94400005T DK0614980T3 DK 0614980 T3 DK0614980 T3 DK 0614980T3 DK 94400005 T DK94400005 T DK 94400005T DK 94400005 T DK94400005 T DK 94400005T DK 0614980 T3 DK0614980 T3 DK 0614980T3
Authority
DK
Denmark
Prior art keywords
trans
immunodeficiency virus
human immunodeficiency
tat variants
contg
Prior art date
Application number
DK94400005T
Other languages
English (en)
Inventor
Majid Mehtali
Tania Sorg
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Application granted granted Critical
Publication of DK0614980T3 publication Critical patent/DK0614980T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK94400005T 1993-01-04 1994-01-03 Trans-dominante TAT-varianter fra humant immundeficiens-virus DK0614980T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9300004A FR2700169B1 (fr) 1993-01-04 1993-01-04 Nouveaux variants trans-dominants TAT du virus de l'immunodéficience humaine.

Publications (1)

Publication Number Publication Date
DK0614980T3 true DK0614980T3 (da) 2005-08-08

Family

ID=9442808

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94400005T DK0614980T3 (da) 1993-01-04 1994-01-03 Trans-dominante TAT-varianter fra humant immundeficiens-virus

Country Status (10)

Country Link
US (2) US5889175A (da)
EP (3) EP1424394A3 (da)
JP (2) JP3613734B2 (da)
AT (1) ATE292981T1 (da)
AU (1) AU668441B2 (da)
CA (1) CA2112652A1 (da)
DE (1) DE69434328T2 (da)
DK (1) DK0614980T3 (da)
ES (1) ES2236688T3 (da)
FR (1) FR2700169B1 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2215483C (fr) * 1995-03-08 2012-01-03 Jean-Francois Zagury Immunogenes denues de toxicite derivant d'une proteine de regulation retrovirale, anticorps, procede de preparation et compositions pharmaceutiques les renfermant
FR2731355B1 (fr) * 1995-03-08 1997-05-30 Neovacs Nouveaux immunogenes, nouveaux anticorps, procede de preparation et compositions pharmaceutiques les renfermant
US5888767A (en) 1996-11-27 1999-03-30 The Johns Hopkins University School Of Medicine Method of using a conditionally replicating viral vector to express a gene
US5885806A (en) * 1995-11-28 1999-03-23 The Johns Hopkins University School Of Medicine Methods to prepare conditionally replicating viral vectors
RO118887B1 (ro) * 1996-01-29 2003-12-30 Virologic, Inc. Metodă pentru determinarea sensibilităţii sau eficacităţii biologice şi rezistenţei omului la medicamentele antivirale
US6686333B1 (en) * 1996-10-04 2004-02-03 The United States Of America As Represented By The Department Of Health And Human Resources Inhibition of HIV replication using soluble Tat peptide analogs
WO1998014587A1 (en) * 1996-10-04 1998-04-09 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPARTEMENT OF HEAL TH AND HUMAN SERVICES Inhibition of hiv replication using soluble tat peptide analogs
US5891994A (en) * 1997-07-11 1999-04-06 Thymon L.L.C. Methods and compositions for impairing multiplication of HIV-1
FR2792206B1 (fr) * 1999-04-13 2006-08-04 Centre Nat Rech Scient Vaccin anti-vih-1 comprenant tout ou partie de la proteine tat de vih-1
FR2792204B1 (fr) * 1999-04-13 2001-07-13 Centre Nat Rech Scient Vaccin anti-vih-1 comprenant tout en partie de la proteine tat de vih-1
US8323928B2 (en) 1999-08-12 2012-12-04 Pin Pharma, Inc. Vaccines and immunotherapeutics derived from the human immunodeficiency virus (HIV) transactivator of transcription protein for the treatment and prevention of HIV disease
US20050226890A1 (en) * 1999-08-12 2005-10-13 Cohen David I Tat-based vaccine compositions and methods of making and using same
CA2398269C (en) * 1999-08-12 2013-04-09 David I. Cohen Non-immunosuppressant hiv tat
US6399067B1 (en) * 2000-04-28 2002-06-04 Thymon L.L.C. Methods and compositions for impairing multiplication of HIV-1
US20080044435A1 (en) * 2004-03-16 2008-02-21 Cohen David I Tat-Based Tolerogen Compositions and Methods of Making and Using Same
US6946267B2 (en) * 2002-03-13 2005-09-20 Dr. Chip Biotechnology Inc. Method for detecting Staphylococcus aureus
US20050208482A1 (en) * 2004-03-16 2005-09-22 Cohen David I Tat-based immunomodulatory compositions and methods for their discovery and use
WO2006088740A2 (en) 2005-02-15 2006-08-24 Thymon, L.L.C. Methods and compositions for impairing multiplication of hiv-1
BRPI1009215B1 (pt) 2009-03-23 2019-10-29 Nanirx Inc composição farmacêutica compreendendo uma sequência de aminoácidos modificada da proteína trans-ativadora de transcrição (tat) do vírus da imunodeficiência humana (hiv) e uso de um polipeptídeo derivado de tat para tratar câncer
IT1397569B1 (it) 2009-12-10 2013-01-16 Icgeb Peptidi e loro derivati che inibiscono il rilascio extracellulare della proteina tat di hiv-1 e la replicazione di hiv-1.
FR2982277B1 (fr) 2011-11-08 2015-08-21 Agronomique Inst Nat Rech Cassette d'expression inductible et ses utilisations
US9663556B2 (en) 2013-10-04 2017-05-30 Pin Pharma, Inc. Treatment of cancers with immunostimulatory HIV tat derivative polypeptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3756789A (en) * 1988-06-16 1990-01-12 St. Louis University Antagonists of viral transactivating proteins

Also Published As

Publication number Publication date
EP1424394A3 (fr) 2005-10-05
AU5280393A (en) 1994-07-14
FR2700169B1 (fr) 1995-03-24
EP1580272A2 (fr) 2005-09-28
US6284252B1 (en) 2001-09-04
JP3613734B2 (ja) 2005-01-26
ATE292981T1 (de) 2005-04-15
CA2112652A1 (fr) 1994-07-05
JPH06234791A (ja) 1994-08-23
ES2236688T3 (es) 2005-07-16
EP1424394A2 (fr) 2004-06-02
EP0614980A1 (fr) 1994-09-14
FR2700169A1 (fr) 1994-07-08
JP2004065256A (ja) 2004-03-04
DE69434328D1 (de) 2005-05-19
AU668441B2 (en) 1996-05-02
EP0614980B1 (fr) 2005-04-13
DE69434328T2 (de) 2006-03-09
EP1580272A3 (fr) 2005-10-05
US5889175A (en) 1999-03-30

Similar Documents

Publication Publication Date Title
DK0614980T3 (da) Trans-dominante TAT-varianter fra humant immundeficiens-virus
ATE173478T1 (de) Varianten des pankreatischen rinder- trypsininhibitors, deren herstellung und verwendung
TR199501134A2 (tr) Memeli ve viral proteinleri asiri ifade edilmesi.
EP0370458A3 (en) Synthetic DNA derived recombinant HIV-1 antigens
RU95115239A (ru) Аналог эритропоэтина
NO20100324L (no) Fremgangsmate for trinnvis festing av polyetylenglykol (PEG) andeler i serie til et polypeptid
DE69635452D1 (de) Hohe expressionsrate des grün-fluoreszierenden proteins
DE69738586D1 (de) Hohe expressionsrate von proteinen
AU4162400A (en) Derivatives of the b or z domain from staphylococcal protein a (spa) interactingwith at least one domain of human factor viii
ATE64619T1 (de) Menschliches apolipoprotein a1 sowie dessen variante, exprimiert in escherichia coli.
FR2669338B1 (da)
NO910982L (no) Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller.
ATE254663T1 (de) Erhöhte produktion von sekretierten proteinen durch rekombinante eukaryotische zellen
ATE143974T1 (de) Peptide des hiv-gag proteins, ihre herstellung und verwendung
DE69534738D1 (de) Leukocyten-aktivierender Faktor
AU637589B2 (en) Ancrod proteins, their production and use
AU1275095A (en) Antiviral composition of viral protein trans-dominant variants
AU3327789A (en) Expression of the hiv 24 kda 24 gag protein in methylotrophic yeast
EP0452319A4 (en) PROTEIN AND CODING SEQUENCE FOR DETECTING AND DIFFERENTIATING SIV AND HIV-2 GROUPS OF VIRUSES.
NO910331D0 (no) Rekombinant plasmid, fremgangsmaate til dets fremstilling og anvendelse av plasmidet i produksjonen av proteiner.
TH14767A (th) กระบวนการสำหรับแยกเอารีคอมบิแนนท์โปรตีนในรูปที่ออกฤทธิ์ทางชีววิทยาออกมาจากสารละลายที่มีโปรตีนที่ไม่ออกฤทธิ์อยู่ด้วย
ZA897509B (en) Novel hiv proteins and peptides useful in the diagnosis,prophylaxis or therapy of aids
NO895154D0 (no) Fremgangsmaate ved fremstilling av et protein eller polypeptid, en dna-sekvens som koder for polypeptidet, en mikroorganisme som inneholder dna-sekvensen samt polypeptidet ogdets anvendelse som et farmasoeytisk preparat.
TH14767EX (th) กระบวนการสำหรับแยกเอารีคอมบิแนนท์โปรตีนในรูปที่ออกฤทธิ์ทางชีววิทยาออกมาจากสารละลายที่มีโปรตีนที่ไม่ออกฤทธิ์อยู่ด้วย